(Q43718452)

26 November 2017

title

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. (English)

1 reference

26 November 2017

main subject

prostatic hypertrophy

1 reference

Meigs JB

1

1 reference

26 November 2017

Mohr B

2

1 reference

26 November 2017

Barry MJ

3

1 reference

26 November 2017

Collins MM

4

1 reference

26 November 2017

McKinlay JB

5

1 reference

26 November 2017

publication date

1 September 2001

1 reference

Journal of Clinical Epidemiology

26 November 2017

published in

1 reference

26 November 2017

volume

54

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

935-944

1 reference

Intrinsic and extrinsic factors controlling benign prostatic growth

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Benign Prostatic Hyperplasia: Antecedents and Natural History

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Physical activity and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Obesity and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Vasectomy and the risk of prostatic cancer and benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Risk factors for surgically treatedbenign prostatic hyperplasia in a prepaid health care plan

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Incidence rates and risk factors for acute urinary retention: the health professionals followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Risk factors for surgery for prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Cigarette smoking and prostatism: A biphasic association?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Association between cigarette smoking and prostatism in a Japanese community

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Cigarette smoking, obesity, and benign prostatic hypertrophy: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Cigarette smoking and serum sex hormones in men

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

Symptoms and signs of prostatism as risk factors for prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900351-1

7 January 2021

10.1016/S0895-4356(01)00351-1

Identifiers

DOI

1 reference

26 November 2017

1 reference